Moderate

Premature ventricular complexes & PVC-induced cardiomyopathy

Ventricular ectopy burden · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Frequent premature ventricular complexes are usually benign but a high burden (often >10-15% of beats) can cause a reversible cardiomyopathy. Management stratifies by symptoms, PVC burden, morphology and underlying structural disease.

Red flags

  • Syncope or pre-syncope with ectopy
  • Falling LV ejection fraction on surveillance
  • Multiform or very high-burden ectopy
  • Exercise-induced ventricular arrhythmia
  • Family history of sudden cardiac death

Assessment

Differential diagnosis

  • Benign idiopathic PVCs (RVOT/LVOT origin)
  • PVCs from structural heart disease
  • Non-sustained VT
  • Electrolyte-driven ectopy
  • Ischaemia-related ectopy
  • Catecholaminergic or inherited arrhythmia

Investigations

  • 12-lead ECG (PVC morphology, QT)
  • 24-48 hour Holter to quantify PVC burden
  • Echocardiogram for LV function and structure
  • Electrolytes including potassium and magnesium
  • Exercise test if exertional symptoms
  • Cardiac MRI if structural disease or scar suspected

Management

  • Quantify PVC burden over 24-48 hours and characterise morphology
  • Assess for underlying structural or ischaemic heart disease
  • Correct electrolyte abnormalities and reduce stimulants/caffeine/alcohol
  • Reassure patients with low burden, normal heart and tolerable symptoms
  • Treat symptoms with a beta-blocker or non-dihydropyridine calcium blocker first-line
  • Monitor LV function when burden exceeds ~10-15%
  • Add or switch to an antiarrhythmic (flecainide if no structural disease, or amiodarone) if needed
  • Refer for catheter ablation if high burden with cardiomyopathy or drug-refractory symptoms
  • Re-echo after burden reduction to confirm recovery of LV function
  • Investigate multiform or exertional PVCs for inherited/structural disease
  • Address reversible triggers at each review
  • Follow up with repeat Holter to document burden reduction

Drugs & doses

Bisoprolol 2.5-10 mg PO OD (or metoprolol 25-100 mg BD)
Verapamil SR 120-240 mg PO OD (if EF preserved)
Flecainide 50-150 mg PO BD (structurally normal heart only)
Amiodarone 200 mg PO OD maintenance (after loading) if other agents fail
Correct magnesium/potassium as needed

Disposition

Outpatient cardiology; electrophysiology referral for high-burden or drug-refractory cases with cardiomyopathy.

Complications & pitfalls

  • PVC-induced cardiomyopathy
  • Progression to sustained VT (with structural disease)
  • Antiarrhythmic proarrhythmia
  • Reduced quality of life from symptoms
  • Missed underlying structural disease

Exam pearls

  • A PVC burden above ~10-15% warrants LV surveillance for reversible cardiomyopathy
  • RVOT PVCs (LBBB, inferior axis) in a normal heart are typically benign and ablatable
  • Ablation can fully reverse PVC-induced cardiomyopathy
  • Reassurance often suffices for low-burden symptomatic ectopy
  • Multiform PVCs or those with structural disease deserve closer evaluation

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.